Vistagen Therapeutics Inc
(VTGN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
| 03-2011 | 12-2010 | 09-2010 | 06-2010 | 03-2010 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 139 | N/A | 2 | 2 | 4 |
| Receivables | 42 | N/A | N/A | N/A | N/A |
| TOTAL | $205 | $N/A | $2 | $2 | $4 |
| Non-Current Assets | |||||
| PPE Net | 88 | N/A | 1 | 1 | 1 |
| Other Non-Current Assets | 31 | 0 | 0 | 0 | 0 |
| TOTAL | $119 | $N/A | $1 | $1 | $1 |
| Total Assets | $324 | $N/A | $3 | $3 | $4 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 6,120 | N/A | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 1,767 | 0 | 3 | 1 | 4 |
| Accrued Expenses | 1,422 | N/A | N/A | N/A | N/A |
| Other current liabilities | 91 | N/A | N/A | N/A | N/A |
| TOTAL | $10,826 | $N/A | $3 | $2 | $4 |
| Non-Current Liabilities | |||||
| Long Term Debt | 2,902 | N/A | N/A | N/A | N/A |
| Deferred Revenues | 79 | N/A | N/A | N/A | N/A |
| Other Non-Current Liabilities | 19,476 | 0 | 0 | 0 | 0 |
| TOTAL | $22,382 | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $33,208 | $N/A | $3 | $2 | $4 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 195 | 195 | 195 | 195 | 195 |
| Common Shares | 5 | N/A | 6 | 6 | 6 |
| Retained earnings | -42,573 | N/A | -56 | -54 | -52 |
| Other shareholders' equity | -184 | 0 | 0 | 0 | 0 |
| TOTAL | $-32,885 | $N/A | $-1 | $1 | $0 |
| Total Liabilities And Equity | $324 | $0 | $3 | $3 | $4 |